| Srilatha Srinivasan, MD | |
|
1920 W. Eldorado Pkwy, Ste 100, Mckinney, TX 75069 | |
| (469) 952-3737 | |
| (469) 952-3738 |
| Full Name | Srilatha Srinivasan |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 1920 W. Eldorado Pkwy, Mckinney, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952374167 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M0576 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primamed Physicians, Pllc | 9234027897 | 54 |
News Archive
As they rush to save lives in the wake of the Haiti earthquake, aid workers also must address myths about disaster relief among the American public. Edward Brown, relief director for Christian humanitarian organization, World Vision, debunks five myths around disaster relief.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation. Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and ultimately lower cost sample preparation.
Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates of fracture in this population.
The lawsuit brought by the Pacific Legal Foundation and a small business owner argued that the overhaul was in violation of the Constitution's Origination Clause.
Oncolytics Biotech Inc. today announced that the first patients have been treated in a Phase 1b study of pembrolizumab (KEYTRUDA) in combination with REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic adenocarcinoma (REO 024).
› Verified 8 days ago
| Entity Name | Primamed Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164494068 PECOS PAC ID: 9234027897 Enrollment ID: O20040316000446 |
News Archive
As they rush to save lives in the wake of the Haiti earthquake, aid workers also must address myths about disaster relief among the American public. Edward Brown, relief director for Christian humanitarian organization, World Vision, debunks five myths around disaster relief.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation. Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and ultimately lower cost sample preparation.
Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates of fracture in this population.
The lawsuit brought by the Pacific Legal Foundation and a small business owner argued that the overhaul was in violation of the Constitution's Origination Clause.
Oncolytics Biotech Inc. today announced that the first patients have been treated in a Phase 1b study of pembrolizumab (KEYTRUDA) in combination with REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic adenocarcinoma (REO 024).
› Verified 8 days ago
| Entity Name | Ucp Physicians Of Central Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922289412 PECOS PAC ID: 3173697935 Enrollment ID: O20080729000203 |
News Archive
As they rush to save lives in the wake of the Haiti earthquake, aid workers also must address myths about disaster relief among the American public. Edward Brown, relief director for Christian humanitarian organization, World Vision, debunks five myths around disaster relief.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation. Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and ultimately lower cost sample preparation.
Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates of fracture in this population.
The lawsuit brought by the Pacific Legal Foundation and a small business owner argued that the overhaul was in violation of the Constitution's Origination Clause.
Oncolytics Biotech Inc. today announced that the first patients have been treated in a Phase 1b study of pembrolizumab (KEYTRUDA) in combination with REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic adenocarcinoma (REO 024).
› Verified 8 days ago
| Entity Name | Nextcare Primary Care Tx Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760875025 PECOS PAC ID: 0840501508 Enrollment ID: O20150622001791 |
News Archive
As they rush to save lives in the wake of the Haiti earthquake, aid workers also must address myths about disaster relief among the American public. Edward Brown, relief director for Christian humanitarian organization, World Vision, debunks five myths around disaster relief.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation. Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and ultimately lower cost sample preparation.
Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates of fracture in this population.
The lawsuit brought by the Pacific Legal Foundation and a small business owner argued that the overhaul was in violation of the Constitution's Origination Clause.
Oncolytics Biotech Inc. today announced that the first patients have been treated in a Phase 1b study of pembrolizumab (KEYTRUDA) in combination with REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic adenocarcinoma (REO 024).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Srilatha Srinivasan, MD 11910 Greenville Avenue, Ste 500, Dallas, TX 75243 Ph: (214) 572-1124 | Srilatha Srinivasan, MD 1920 W. Eldorado Pkwy, Ste 100, Mckinney, TX 75069 Ph: (469) 952-3737 |
News Archive
As they rush to save lives in the wake of the Haiti earthquake, aid workers also must address myths about disaster relief among the American public. Edward Brown, relief director for Christian humanitarian organization, World Vision, debunks five myths around disaster relief.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation. Highly selective extractions with AFFINILUTE MIPs are considerably simplified resulting in faster, more robust and ultimately lower cost sample preparation.
Low bone mineral density in HIV-infected patients is common and raises concerns about increased risks of fracture. Although there have been several studies regarding bone mineral density, there have been few data on rates of fracture in this population.
The lawsuit brought by the Pacific Legal Foundation and a small business owner argued that the overhaul was in violation of the Constitution's Origination Clause.
Oncolytics Biotech Inc. today announced that the first patients have been treated in a Phase 1b study of pembrolizumab (KEYTRUDA) in combination with REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic adenocarcinoma (REO 024).
› Verified 8 days ago
George W Childress, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6171 Virginia Pkwy Ste 200, Mckinney, TX 75071 Phone: 972-548-5377 Fax: 972-548-5447 | |
Melony Ann Chilcoat, APRN, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2740 Virginia Pkwy Ste 100, Mckinney, TX 75071 Phone: 214-414-2880 Fax: 214-279-9639 | |
Dr. Kedrica Massa Taylor, DNP, APRN, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1703 Rockhill Rd Apt 1131, Mckinney, TX 75069 Phone: 918-408-0560 | |
Dr. John L Washburn Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5220 W University Dr Ste 100, Mckinney, TX 75071 Phone: 469-800-5100 Fax: 469-800-5110 | |
Tina M Gingrich, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4510 Medical Center Dr, Mckinney, TX 75069 Phone: 214-295-8675 Fax: 866-207-2534 | |
Ambreen Ashfaque, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4201 Medical Center Dr, Suite 380, Mckinney, TX 75069 Phone: 972-529-6939 Fax: 972-529-6935 | |
Mr. Billy R Boring Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1441 Redbud Blvd, Ste 111, Mckinney, TX 75069 Phone: 972-542-2683 Fax: 972-548-7657 |